Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | WDR5 | P61964 | 1/20 | 0.31 |
| ▸ | SELL | P14151 | 1/20 | 0.31 |
| ▸ | SELP | P16109 | 1/20 | 0.31 |
| ▸ | TYMS | P04818 | 1/20 | 0.30 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3903646 | 0.83 | CYP1A2 (0.54) | CYP1A2HSD17B10ALDH1A1ALOX15WDR5 | |
| SCHEMBL30141 | 0.80 | CYP1A2 (0.78) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| SCHEMBL30117300 | 0.80 | CYP1A2 (0.78) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| Potassium SCHEMBL15992061 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| SCHEMBL8716584 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| SCHEMBL2244837 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| Potassium SCHEMBL11899737 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| SCHEMBL2249624 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| Water SCHEMBL10822718 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 | |
| SCHEMBL15992060 | 0.78 | CYP1A2 (0.74) | CYP1A2PARP1HSD17B10ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7253316-B2 | Flexible method for the joint production of (i) formic acid, (ii) a carboxylic acid comprising at least two carbon atoms and/or the derivatives thereof, and (iii) a carboxylic acid anhydride | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-07 | — | — | US | disclosed |
| US-20060052631-A1 | Flexible method for the joint production of (i) formic acid, (ii) a carboxylic acid comprising at least two carbon atoms and/or the derivatives thereof, and (iii) a carboxylic acid anhydride | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| CN-1708473-A | Flexible method for the joint production of (i) formic acid, (ii) a carboxylic acid comprising at least two carbon atoms and/or the derivatives thereof, and (iii) a carboxylic acid anhydride | BASF AG (DE) | 2005-12-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052631-A1 | Flexible method for the joint production of (i) formic acid, (ii) a carboxylic acid comprising at least two carbon atoms and/or the derivatives thereof, and (iii) a carboxylic acid anhydride | CA3, CA1, CA6 | CYP1A2 619/4885PARP1 3197/4885HSD17B10 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.